John Hanna (CDNA) reports option exercise and recent 10b5-1 sales
Rhea-AI Filing Summary
John Hanna submitted a Form 144 reporting proposed dispositions of common stock. The filing lists 29,294 shares tied to an exercise of stock options with a 06/11/2026 action date, and 10,887 shares related to restricted stock units with a 04/15/2025 action date. The excerpt also shows recent 10b5-1 sales of 4,835 shares on 06/04/2026 and 10,282 shares on 04/16/2026 with dollar proceeds noted in the table.
Positive
- None.
Negative
- None.
Insights
Form 144 lists option exercises and scheduled dispositions under a 10b5-1 plan.
The filing shows an exercise of stock options for 29,294 shares (action date 06/11/2026) and restricted stock units of 10,887 shares (action date 04/15/2025), each labeled as issuer transactions. Recent 10b5-1 sales of 4,835 and 10,282 shares are recorded with cash proceeds in the excerpt.
Cash‑flow treatment and whether shares will be sold in market or withheld for taxes are not detailed in the excerpt; subsequent filings or confirmations would state settlement mechanics and net proceeds.
Transactions appear procedural: exercises and scheduled rule‑based sales rather than discretionary open‑market announcements.
The excerpt identifies 10b5-1 sales on 04/16/2026 and 06/04/2026 with reported share counts and dollar amounts. The filing lists the broker/dealer intermediary and Nasdaq as the market.
Timing and any holding‑period implications are not provided in the excerpt; further SEC filings could show actual transfer dates or net share changes.